company background image
SYK logo

Stryker NYSE:SYK Stock Report

Last Price

US$354.08

Market Cap

US$134.6b

7D

-0.4%

1Y

27.9%

Updated

18 Mar, 2024

Data

Company Financials +

SYK Stock Overview

Stryker Corporation operates as a medical technology company.

SYK fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance4/6
Financial Health4/6
Dividends4/6

Narratives

Beta

Narratives bring a range of perspectives from our community.

Stryker Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Stryker
Historical stock prices
Current Share PriceUS$354.08
52 Week HighUS$361.41
52 Week LowUS$249.98
Beta0.90
1 Month Change1.37%
3 Month Change21.27%
1 Year Change27.91%
3 Year Change52.57%
5 Year Change81.42%
Change since IPO65,268.58%

Recent News & Updates

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14
Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21
At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Recent updates

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

Mar 14
Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Feb 21
At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Feb 10
Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Feb 02

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Feb 02
Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Jan 24
Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Jan 02
Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Stryker: Mako Shoulder And Spine Launches Are On The Way

Dec 31

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 22
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Dec 08
Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Why Stryker Is An Awesome Healthcare Compounder

Nov 30

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Nov 10
Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Oct 19
Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Oct 13

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Oct 08
Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) A Risky Investment?

Sep 26
Is Stryker (NYSE:SYK) A Risky Investment?

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Aug 22

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Jul 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Jul 06
Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Jun 17
These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well

Stryker: Good Prospects

Jun 14

With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

May 24
With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case

Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

May 01
Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Apr 18
Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Apr 06
Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Is Stryker (NYSE:SYK) Using Too Much Debt?

Feb 27
Is Stryker (NYSE:SYK) Using Too Much Debt?

Stryker: Typically Excellent, Typically Expensive

Feb 16

Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback

Feb 07

If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Feb 02
If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity

Stryker Non-GAAP EPS of $3.00 beats by $0.16, revenue of $5.2B beats by $230M

Jan 31

Stryker initiated at sector weight by KeyBanc on limited upside potential

Jan 25

Stryker: Excellent Recent And Continuing Performance

Jan 09

Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

Jan 08
Be Wary Of Stryker (NYSE:SYK) And Its Returns On Capital

At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Dec 26
At US$243, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?

Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Dec 14
Stryker's (NYSE:SYK) Upcoming Dividend Will Be Larger Than Last Year's

Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Dec 12
Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker lifts dividend by 7.9% to $0.75/share

Dec 07

Stryker Q3 2022 Earnings Preview

Oct 28

Stryker (NYSE:SYK) Has A Pretty Healthy Balance Sheet

Oct 28
Stryker (NYSE:SYK) Has A Pretty Healthy Balance Sheet

Shareholder Returns

SYKUS Medical EquipmentUS Market
7D-0.4%-1.4%0.5%
1Y27.9%11.9%29.0%

Return vs Industry: SYK exceeded the US Medical Equipment industry which returned 11.9% over the past year.

Return vs Market: SYK underperformed the US Market which returned 29% over the past year.

Price Volatility

Is SYK's price volatile compared to industry and market?
SYK volatility
SYK Average Weekly Movement2.6%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: SYK has not had significant price volatility in the past 3 months.

Volatility Over Time: SYK's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
194152,000Kevin Lobohttps://www.stryker.com

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Stryker Corporation Fundamentals Summary

How do Stryker's earnings and revenue compare to its market cap?
SYK fundamental statistics
Market capUS$134.64b
Earnings (TTM)US$3.17b
Revenue (TTM)US$20.50b

42.5x

P/E Ratio

6.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SYK income statement (TTM)
RevenueUS$20.50b
Cost of RevenueUS$7.40b
Gross ProfitUS$13.10b
Other ExpensesUS$9.93b
EarningsUS$3.17b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)8.32
Gross Margin63.89%
Net Profit Margin15.44%
Debt/Equity Ratio69.9%

How did SYK perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

37%

Payout Ratio

Does SYK pay a reliable dividends?

See SYK dividend history and benchmarks
When do you need to buy SYK by to receive an upcoming dividend?
Stryker dividend dates
Ex Dividend DateMar 27 2024
Dividend Pay DateApr 30 2024
Days until Ex dividend8 days
Days until Dividend pay date42 days

Does SYK pay a reliable dividends?

See SYK dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.